Evid Invest
Who owns REGNWhat REGN owns

Who owns REGENERON PHARMACEUTICALS, INC.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of REGN from SEC Form 13F filings across 1,423 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 1,423 institutions disclosed 88.6M shares of REGENERON PHARMACEUTICALS, INC. worth $67.57B — about 87.1% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.

1,423

13F holders

$67.57B

value, 2026 filers

87.1%

of shares outstanding (88.6M sh)

214

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of REGN's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1BlackRock, Inc.8.8M$6.71B0.1%8.7%-2.9%
2VANGUARD CAPITAL MANAGEMENT LLC6.5M$4.95B0.1%6.4%-1.6%
3STATE STREET CORP4.9M$3.70B0.1%4.8%+1.0%
4Dodge & Cox4.8M$3.62B1.9%4.7%-2.0%
5Invesco Ltd.3.7M$2.82B0.2%3.7%-5.6%
6JPMORGAN CHASE & CO3.3M$2.48B0.1%3.3%-12.4%
7VANGUARD PORTFOLIO MANAGEMENT LLC3.1M$2.36B0.1%3.1%-2.0%
8FRANKLIN TEMPLETON INC3.0M$2.75B0.6%2.9%+6.5%
9GEODE CAPITAL MANAGEMENT, LLC2.6M$1.99B0.1%2.6%+0.3%
10Nuveen, LLC2.0M$1.48B0.4%1.9%-3.2%
11LOOMIS SAYLES & CO L P1.7M$1.30B1.7%1.7%-7.7%
12MORGAN STANLEY1.4M$1.04B0.1%1.3%-1.8%
13AQR CAPITAL MANAGEMENT LLC1.3M$978.9M0.3%1.3%+16.5%
14WELLINGTON MANAGEMENT GROUP LLP1.3M$964.5M0.2%1.3%+0.1%
15BANK OF AMERICA CORP /DE/1.2M$884.4M0.1%1.1%-9.7%
16Amundi1.2M$872.8M0.2%1.1%+13.6%
17PRICE T ROWE ASSOCIATES INC /MD/1.1M$837.0M0.1%1.1%-27.8%
18FMR LLC1.0M$785.0M0.0%1%+24.4%
19NORTHERN TRUST CORP997,639$756.5M0.1%1%+8.9%
20TWO SIGMA INVESTMENTS, LP869,505$659.3M0.5%0.9%+32.5%
21UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC854,258$647.8M0.1%0.8%+19.2%
22Capital World Investors832,633$631.4M0.1%0.8%+2.2%
23FIRST TRUST ADVISORS LP826,770$626.9M0.4%0.8%+51.1%
24CHARLES SCHWAB INVESTMENT MANAGEMENT INC773,243$586.3M0.1%0.8%-8.6%
25Bank of New York Mellon Corp734,673$557.1M0.1%0.7%-3.1%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.